Vertex Pharmaceuticals (VRTX) Fails to deliver data

Key failure to deliver metrics for Vertex Pharmaceuticals:

• Last SEC data release: 2026-01-14
• Last 15 days FTD volume: €0.43 M
• Last 3 months FTD volume: €37.95 M
• Last 12 months FTD volume: €0.10 B

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Vertex Pharmaceuticals (VRTX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Vertex Pharmaceuticals (VRTX) - since 2013

Vertex Pharmaceuticals (VRTX) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Johnson & Johnson JNJ	€24.94 M	€0.10 B	🇺🇸 USA
AbbVie ABBV	€49.63 M	€98.25 M	🇺🇸 USA
Gilead Sciences GILD	€24.58 M	€0.24 B	🇺🇸 USA
Merck MRK	€36.21 M	€0.14 B	🇺🇸 USA
Bristol-Myers Squibb BMY	€31.05 M	€81.93 M	🇺🇸 USA
Enanta Pharmaceuticals ENTA	€0.3 M	€1.05 M	🇺🇸 USA